{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T07:23:59Z","timestamp":1746257039806},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Serological testing of patients consulting for typical erythema migrans (EM) is not recommended in European recommendations for diagnosis of Lyme borreliosis (LB). Little is known on the level of adherence of French general practitioners to these recommendations. The objectives were to estimate the proportion of Lyme borreliosis serological test prescription in patients with erythema migrans seen in general practice consultations in France, and to study the factors associated with this prescription.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>LB cases with an EM reported by the French general practitioners (GPs) of the <jats:italic>Sentinelles network<\/jats:italic> between January 2009 and December 2020 were included. To assess the associations with a prescription of a serological test, multilevel logistic regression models were used.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 1,831 EM cases included, a prescription for a LB serological test was requested in 24.0% of cases. This proportion decreased significantly over the study period, from 46.8% in 2009 to 15.8% in 2020. A LB serological prescription was associated with patients with no reported tick bite (Odds Ratio (OR): 1.95; 95% confidence interval [1.23\u20133.09]), multiple EM (OR: 3.82 [1.63\u20138.92]), EM of five centimeters or more (OR: 4.34 [2.33\u20138.08]), and GPs having diagnosed less than one EM case per year during the study period (OR: 5.28 [1.73\u201316.11]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Serological testing of patients consulting for EM is not recommended in European recommendations for diagnosis of Lyme borreliosis. Therefore, the significant decrease in the rate of LB serological test for EM over the study period is encouraging. The factors identified in this study can be used to improve messaging to GPs and patients. Further efforts are needed to continue to disseminate diagnostic recommendations for LB to GPs, especially those who rarely see patients with EM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-023-02108-3","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T18:04:13Z","timestamp":1692900253000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and factors associated with a prescription of a Lyme borreliosis serology for erythema migrans diagnosis in general practice: a study from the French sentinel network, 2009\u20132020"],"prefix":"10.1186","volume":"24","author":[{"given":"Camille","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Figoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Souty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Septfons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"de Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henriette","family":"de Valk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hanslik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Jaulhac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Blanchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"2108_CR1","doi-asserted-by":"publisher","first-page":"m1041","DOI":"10.1136\/bmj.m1041","volume":"369","author":"BJ Kullberg","year":"2020","unstructured":"Kullberg BJ, Vrijmoeth HD, van de Schoor F, Hovius JW. Lyme borreliosis: diagnosis and management. BMJ. 2020;369:m1041.","journal-title":"BMJ"},{"issue":"2","key":"2108_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM200107123450207","volume":"345","author":"AC Steere","year":"2001","unstructured":"Steere AC. Lyme disease. N Engl J Med. 2001;345(2):115\u201325.","journal-title":"N Engl J Med"},{"issue":"7","key":"2108_CR3","first-page":"684","volume":"371","author":"ED Shapiro","year":"2014","unstructured":"Shapiro ED. Lyme disease. N Engl J Med. 2014;371(7):684.","journal-title":"N Engl J Med"},{"issue":"6","key":"2108_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2165\/0128071-200809060-00002","volume":"9","author":"RR Mullegger","year":"2008","unstructured":"Mullegger RR, Glatz M. Skin manifestations of lyme borreliosis: diagnosis and management. Am J Clin Dermatol. 2008;9(6):355\u201368.","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"2108_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","volume":"100","author":"RB Nadelman","year":"1996","unstructured":"Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med. 1996;100(5):502\u20138.","journal-title":"Am J Med"},{"key":"2108_CR6","volume-title":"Bilan Annuel 2020","author":"Institut Pierre Louis d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP), UMR-S\u00a01136 (Unit\u00e9 Mixte de Recherche en Sant\u00e9)","year":"2020","unstructured":"Institut Pierre Louis d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP), UMR-S\u00a01136 (Unit\u00e9 Mixte de Recherche en Sant\u00e9). Bilan Annuel 2020. Paris, France: R\u00e9seau Sentinelles; 2020."},{"issue":"11","key":"2108_CR7","doi-asserted-by":"publisher","first-page":"1800134","DOI":"10.2807\/1560-7917.ES.2019.24.11.1800134","volume":"24","author":"A Septfons","year":"2019","unstructured":"Septfons A, Goronflot T, Jaulhac B, Roussel V, De Martino S, Guerreiro S, et al. Epidemiology of Lyme borreliosis through two surveillance systems: the national Sentinelles GP network and the national hospital discharge database, France, 2005 to 2016. Eurosurveillance. 2019;24(11):1800134.","journal-title":"Eurosurveillance"},{"issue":"2","key":"2108_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1086\/589316","volume":"47","author":"A Weinstein","year":"2008","unstructured":"Weinstein A. Editorial commentary: laboratory testing for Lyme disease: time for a change? Clin Infect Dis. 2008;47(2):196\u20137.","journal-title":"Clin Infect Dis"},{"key":"2108_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12879-016-1468-4","volume":"16","author":"MM Leeflang","year":"2016","unstructured":"Leeflang MM, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, et al. The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. BMC Infect Dis. 2016;16:140.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2108_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.medmal.2018.11.011","volume":"49","author":"C Eldin","year":"2019","unstructured":"Eldin C, Raffetin A, Bouiller K, Hansmann Y, Roblot F, Raoult D, et al. Review of european and american guidelines for the diagnosis of Lyme borreliosis. Med Mal Infect. 2019;49(2):121\u201332.","journal-title":"Med Mal Infect"},{"issue":"10","key":"2108_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cmi.2019.02.020","volume":"25","author":"BJ Webber","year":"2019","unstructured":"Webber BJ, Burganowski RP, Colton L, Escobar JD, Pathak SR, Gambino-Shirley KJ. Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study. Clin Microbiol Infect. 2019;25(10):1233\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2108_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","volume":"17","author":"G Stanek","year":"2011","unstructured":"Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17(1):69\u201379.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"2108_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cmi.2017.08.025","volume":"24","author":"RB Dessau","year":"2018","unstructured":"Dessau RB, van Dam AP, Fingerle V, Gray J, Hovius JW, Hunfeld KP, et al. To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clin Microbiol Infect. 2018;24(2):118\u201324.","journal-title":"Clin Microbiol Infect"},{"key":"2108_CR14","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Recommandation de bonne pratique - Borr\u00e9liose de Lyme et autres maladies vectorielles \u00e0 tiques (MVT). 2018."},{"issue":"5","key":"2108_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.medmal.2019.04.381","volume":"49","author":"J Figoni","year":"2019","unstructured":"Figoni J, Chirouze C, Hansmann Y, Lemogne C, Hentgen V, Saunier A, et al. Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis. Med Mal Infect. 2019;49(5):318\u201334.","journal-title":"Med Mal Infect"},{"key":"2108_CR16","unstructured":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise (SPILF). Borr\u00e9liose de Lyme: d\u00e9marche diagnostiques, th\u00e9rapeutiques et pr\u00e9ventives. 2006."},{"issue":"5","key":"2108_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1017\/S0950268805004413","volume":"133","author":"L Letrilliart","year":"2005","unstructured":"Letrilliart L, Ragon B, Hanslik T, Flahault A. Lyme disease in France: a primary care-based prospective study. Epidemiol Infect. 2005;133(5):935\u201342.","journal-title":"Epidemiol Infect"},{"issue":"10","key":"2108_CR18","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s10096-014-2129-4","volume":"33","author":"J Coumou","year":"2014","unstructured":"Coumou J, Hovius JW, van Dam AP. Borrelia burgdorferi sensu lato serology in the Netherlands: guidelines versus daily practice. Eur J Clin Microbiol Infect Dis. 2014;33(10):1803\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2108_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/1471-2334-10-317","volume":"10","author":"RB Dessau","year":"2010","unstructured":"Dessau RB, Bangsborg JM, Ejlertsen T, Skarphedinsson S, Schonheyder HC. Utilization of serology for the diagnosis of suspected Lyme borreliosis in Denmark: survey of patients seen in general practice. BMC Infect Dis. 2010;10:317.","journal-title":"BMC Infect Dis"},{"key":"2108_CR20","doi-asserted-by":"crossref","unstructured":"Hillerdal H, Henningsson AJ. Serodiagnosis of Lyme borreliosis-is IgM in serum more harmful than helpful? Eur J Clin Microbiol Infect Dis. 2021.","DOI":"10.1007\/s10096-020-04093-2"},{"key":"2108_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12963-014-0019-8","volume":"12","author":"C Souty","year":"2014","unstructured":"Souty C, Turbelin C, Blanchon T, Hanslik T, Le Strat Y, Boelle PY. Improving disease incidence estimates in primary care surveillance systems. Popul Health Metr. 2014;12:19.","journal-title":"Popul Health Metr"},{"key":"2108_CR22","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Borr\u00e9liose de Lyme - Rapport du groupe de travail. 2014."},{"issue":"2","key":"2108_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/fampra\/cmy038","volume":"36","author":"MM Methorst","year":"2019","unstructured":"Methorst MM, Uijen AA, Schers H, Tiersma WP, Hautvast JLA, van Jaarsveld CHM. Incidence, presentation and management of Lyme disease in dutch general practice. Fam Pract. 2019;36(2):110\u20136.","journal-title":"Fam Pract"},{"issue":"1","key":"2108_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ttbdis.2016.06.006","volume":"8","author":"KE Eliassen","year":"2017","unstructured":"Eliassen KE, Berild D, Reiso H, Grude N, Christophersen KS, Finckenhagen C, et al. Incidence and antibiotic treatment of erythema migrans in Norway 2005\u20132009. Ticks Tick Borne Dis. 2017;8(1):1\u20138.","journal-title":"Ticks Tick Borne Dis"},{"issue":"1","key":"2108_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12875-018-0729-2","volume":"19","author":"E Botman","year":"2018","unstructured":"Botman E, Ang CW, Joosten JHK, Slottje P, van der Wouden JC, Maarsingh OR. Diagnostic behaviour of general practitioners when suspecting Lyme disease: a database study from 2010\u20132015. BMC Fam Pract. 2018;19(1):43.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"2108_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12875-017-0636-y","volume":"18","author":"S Gasmi","year":"2017","unstructured":"Gasmi S, Ogden NH, Leighton PA, Adam-Poupart A, Milord F, Lindsay LR, et al. Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008\u20132015. BMC Fam Pract. 2017;18(1):65.","journal-title":"BMC Fam Pract"},{"issue":"9","key":"2108_CR27","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s10096-012-1580-3","volume":"31","author":"K Vanthomme","year":"2012","unstructured":"Vanthomme K, Bossuyt N, Boffin N, Van Casteren V. Incidence and management of presumption of Lyme borreliosis in Belgium: recent data from the sentinel network of general practitioners. Eur J Clin Microbiol Infect Dis. 2012;31(9):2385\u201390.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"2108_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/13814788.2020.1732347","volume":"26","author":"TM Vreugdenhil","year":"2020","unstructured":"Vreugdenhil TM, Leeflang M, Hovius JW, Sprong H, Bont J, Ang CW, et al. Serological testing for Lyme Borreliosis in general practice: a qualitative study among dutch general practitioners. Eur J Gen Pract. 2020;26(1):51\u20137.","journal-title":"Eur J Gen Pract"},{"issue":"4","key":"2108_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1370\/afm.117","volume":"2","author":"AH Ramsey","year":"2004","unstructured":"Ramsey AH, Belongia EA, Chyou PH, Davis JP. Appropriateness of Lyme disease serologic testing. Ann Fam Med. 2004;2(4):341\u20134.","journal-title":"Ann Fam Med"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02108-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-023-02108-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02108-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:07:53Z","timestamp":1700489273000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-023-02108-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2108"],"URL":"https:\/\/doi.org\/10.1186\/s12875-023-02108-3","relation":{},"ISSN":["2731-4553"],"issn-type":[{"type":"electronic","value":"2731-4553"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol was conducted in agreement with the Helsinki declaration. Ethical approval was obtained from the French Data Protection Agency (CNIL #471393) and the French ethical research committee (Comit\u00e9 de protection des personnes \u2013 CPP).The French Sentinelles Network database is built and used in accordance with French legislation on health data collection and treatment. It contains pseudonymized data of the patients of the general practitioners participating in the network, except for those patients who object. This study is therefore exempt from informed consent by each patient.This research work was conducted by members of the Sentinel Network team, so no special request was needed to access the database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"163"}}